Bevacizumab for the treatment of nonsquamous non-small-cell lung cancer in Portugal: a retrospective, multicenter study
Fernanda Estevinho1, Marta Soares2, Isabel Azevedo2, Henrique Queiroga3, Bárbara Parente4, Ulisses Brito5, Encarnação Teixeira6, Renato Sotto-Mayor7, António Araújo81Medical Oncology Resident, Department of Medical Oncology,...
Main Authors: | Estevinho F, Soares M, Azevedo I, Queiroga H, Parente B, Brito U, Teixeira E, Sotto-Mayor R, Araújo A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-03-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/bevacizumab-for-the-treatment-of-nonsquamous-non-small-cell-lung-cance-a9470 |
Similar Items
-
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
by: Yasuhiro Tsutani, et al.
Published: (2018-12-01) -
Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience
by: Laurent Greillier, et al.
Published: (2016-10-01) -
Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non–small‐cell lung cancer
by: Nicole F. Laslett, et al.
Published: (2018-07-01) -
Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study
by: Arai, D., et al.
Published: (2022) -
Multicenter study of carbon‐ion radiation therapy for nonsquamous cell carcinomas of the oral cavity
by: Hiroaki Ikawa, et al.
Published: (2019-09-01)